153 related articles for article (PubMed ID: 7030273)
1. Preparation of a BCG substrain specific elicitin.
Niculescu D; Stavri D
Arch Roum Pathol Exp Microbiol; 1981; 40(2):117-22. PubMed ID: 7030273
[No Abstract] [Full Text] [Related]
2. [Immunologic characterization of fractions of the BCG strain of M. bovis isolated by chromatofocusing].
Nyabenda J; Pierre M; Keuterickx F; de Backer P
Dev Biol Stand; 1986; 58 ( Pt A)():43-52. PubMed ID: 3297875
[No Abstract] [Full Text] [Related]
3. [Model of allergy of the immediate type to BCG and analysis of allergic reactivity in BCG vaccination in experiments].
Beklemishev ND; Sukhodoeva GS; Bul'vakhter IaL
Probl Tuberk; 1975; (12):53-8. PubMed ID: 768978
[No Abstract] [Full Text] [Related]
4. Production and purification of eta (ETA) precipitinogen, species-specific to mycobacterium tuberculosis and its intradermal reactivity.
Hirai T; Yamanouchi T
Dev Biol Stand; 1986; 58 ( Pt B)():565-8. PubMed ID: 3111903
[TBL] [Abstract][Full Text] [Related]
5. MPB70, a unique antigenic protein isolated from the culture filtrate of BCG substrain Tokyo.
Nagai S; Miura K; Tokunaga T; Harboe M
Dev Biol Stand; 1986; 58 ( Pt B)():511-6. PubMed ID: 3301461
[No Abstract] [Full Text] [Related]
6. [Immunological properties of cellular membranes of Mycobacterium bovis].
Romanova RIu; Pavlova VT; Il'ina IN; Kliuev VA
Probl Tuberk; 1978 Aug; (8):67-70. PubMed ID: 360207
[No Abstract] [Full Text] [Related]
7. Comparison of bcg strains for delayed hypersensitivity induction tested in vivo in guinea pigs and in vitro.
Smerák P; Průchová J; Sír Z
J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):435-44. PubMed ID: 6761395
[TBL] [Abstract][Full Text] [Related]
8. The isolation from romanian BCG substrain of non cross reacting antigens to Mycobacterium tuberculosis H37Rv strain.
Niculescu D; Stavri D; Stavri H; Claiciu I; Bărbulescu R
Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):213-9. PubMed ID: 6424629
[No Abstract] [Full Text] [Related]
9. [Variability of the BCG Moreau substrain. II. Comparison of the allergizing and protective properties of BCG substrains of various origins].
Janaszek W
Med Dosw Mikrobiol; 1983; 35(2):97-105. PubMed ID: 6369043
[No Abstract] [Full Text] [Related]
10. Evaluation of representative BCG strains by special methods using experimental animals.
Průchová J; Smerák P; Sír Z; Mára M
Dev Biol Stand; 1986; 58 ( Pt A)():73-7. PubMed ID: 3297878
[No Abstract] [Full Text] [Related]
11. Comparative studies with various substrains of Mycobacterium bovis BCG on the production of an antigenic protein, MPB70.
Miura K; Nagai S; Kinomoto M; Haga S; Tokunaga T
Infect Immun; 1983 Feb; 39(2):540-5. PubMed ID: 6339381
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
13. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle.
Mustafa AS; Skeiky YA; Al-Attiyah R; Alderson MR; Hewinson RG; Vordermeier HM
Infect Immun; 2006 Aug; 74(8):4566-72. PubMed ID: 16861643
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
de Lisle GW; Wards BJ; Buddle BM; Collins DM
Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of pulmonary Mycobacterium bovis infection: basic principles established by the rabbit model.
Dannenberg AM
Tuberculosis (Edinb); 2001; 81(1-2):87-96. PubMed ID: 11463228
[No Abstract] [Full Text] [Related]
17. Antigenic cross-reactivity between Mycobacterium bovis (BCG) and Leishmania donovani.
Smrkovski LL; Larson CL
Infect Immun; 1977 Nov; 18(2):561-2. PubMed ID: 336551
[TBL] [Abstract][Full Text] [Related]
18. [Purification, characterization and immunological study of 2 protein antigens of the BCG strain Mycobacterium bovis].
De Bruyn J; Turneer M
Bull Mem Acad R Med Belg; 1988; 143(1-2):157-70. PubMed ID: 3052672
[No Abstract] [Full Text] [Related]
19. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
[TBL] [Abstract][Full Text] [Related]
20. [The formation of delayed hypersensitivity to mycobacterial antigens].
Liashchenko KP; Bobrovnik SA; Komissarenko SV
Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):66-8. PubMed ID: 1882613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
